Literature DB >> 10099828

Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.

V Reinke1, D M Bortner, L L Amelse, K Lundgren, M P Rosenberg, C A Finlay, G Lozano.   

Abstract

Expression of a beta-lactoglobulin (BLG)/mdm2 transgene (BLGmdm2) in the epithelial cells of the mouse mammary gland causes an uncoupling of S phase from M phase, resulting in polyploidy and tumor formation. The cell cycle defects are independent of interactions with p53. Because MDM2 also binds and activates the S phase-specific transcription factor E2F1, we hypothesized that increased E2F1 activity causes the development of the BLGmdm2 phenotype. We, therefore, generated BLGmdm2 mice that were null for E2F1. We observed no notable differences in histology or cyclin gene expression between BLGmdm2 and BLGmdm2/E2F1-/- mice, indicating that endogenous E2F1 activity was not required for the BLGmdm2 phenotype. Because, depending on the experimental system, either loss of E2F1 function or overexpression of E2F1 results in transformation, we also tested whether overexpression of E2F1 augmented the severity of the BLGmdm2 phenotype by generating mice that were bitransgenic for BLGmdm2 and BLGE2F1. We observed a unique mixture of the two single transgenic phenotypes histologically and found no significant changes in cyclin levels, indicating that overexpression of E2F1 had no effect on the BLGmdm2 transgenic phenotype. Thus, increased expression or absence of E2F1 does not affect the ability of MDM2 to disrupt the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10099828

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  8 in total

1.  MDM2 interacts with the C-terminus of the catalytic subunit of DNA polymerase epsilon.

Authors:  N Vlatkovic; S Guerrera; Y Li; S Linn; D S Haines; M T Boyd
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

2.  A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene.

Authors:  S Bartl; J Ban; H Weninger; G Jug; H Kovar
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.

Authors:  G Ganguli; J Abecassis; B Wasylyk
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

4.  Stimulation of human DNA polymerase epsilon by MDM2.

Authors:  Hitomi Asahara; Ying Li; Jill Fuss; Dale S Haines; Nikolina Vlatkovic; Mark T Boyd; Stuart Linn
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

5.  MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity.

Authors:  Meenalakshmi Chinnam; Chao Xu; Rati Lama; Xiaojing Zhang; Carlos D Cedeno; Yanqing Wang; Aimee B Stablewski; David W Goodrich; Xinjiang Wang
Journal:  PLoS Genet       Date:  2022-05-19       Impact factor: 6.020

6.  Mdm2 and tumorigenesis: evolving theories and unsolved mysteries.

Authors:  Emir Senturk; James J Manfredi
Journal:  Genes Cancer       Date:  2012-03

7.  Protecting the genome from mdm2 and mdmx.

Authors:  Alexia N Melo; Christine M Eischen
Journal:  Genes Cancer       Date:  2012-03

Review 8.  The role of the ubiquitination-proteasome pathway in breast cancer: use of mouse models for analyzing ubiquitination processes.

Authors:  Sabrina Rossi; Massimo Loda
Journal:  Breast Cancer Res       Date:  2002-10-07       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.